Molecular Devices Buys Arcturus' Laser Capture Microdissection Business for $10M
Molecular Devices has acquired the laser capture microdissection business of Arcturus Biosicence for $10 million in cash, the company said this week.
Under the terms of the agreement, Molecular Devices acquired Arcturus' LCM-related assets and hired 42 Arcturus employees. LCM operations will immediately move to Molecular Devices' headquarters in Sunnyvale, Calif. The company expects that the acquisition will increase its revenues by $8 million to $10 million this year.